These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 24704198

  • 1. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
    Béduneau A, Tempesta C, Fimbel S, Pellequer Y, Jannin V, Demarne F, Lamprecht A.
    Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
    Antoine D, Pellequer Y, Tempesta C, Lorscheidt S, Kettel B, Tamaddon L, Jannin V, Demarne F, Lamprecht A, Béduneau A.
    Int J Pharm; 2015 Mar 15; 481(1-2):27-36. PubMed ID: 25601199
    [Abstract] [Full Text] [Related]

  • 4. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design.
    Chen XM, Elisia I, Kitts DD.
    J Pharmacol Toxicol Methods; 2010 Mar 15; 61(3):334-42. PubMed ID: 20159047
    [Abstract] [Full Text] [Related]

  • 5. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
    Araújo F, Sarmento B.
    Int J Pharm; 2013 Dec 15; 458(1):128-34. PubMed ID: 24120728
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
    Antunes F, Andrade F, Araújo F, Ferreira D, Sarmento B.
    Eur J Pharm Biopharm; 2013 Apr 15; 83(3):427-35. PubMed ID: 23159710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro investigation regarding the effects of Gelucire® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates.
    Dubray O, Jannin V, Demarne F, Pellequer Y, Lamprecht A, Béduneau A.
    Int J Pharm; 2016 Dec 30; 515(1-2):293-299. PubMed ID: 27720954
    [Abstract] [Full Text] [Related]

  • 9. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation.
    Li N, Wang D, Sui Z, Qi X, Ji L, Wang X, Yang L.
    Tissue Eng Part C Methods; 2013 Sep 30; 19(9):708-19. PubMed ID: 23350801
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
    Gagnon M, Zihler Berner A, Chervet N, Chassard C, Lacroix C.
    J Microbiol Methods; 2013 Sep 30; 94(3):274-9. PubMed ID: 23835135
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans.
    Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL.
    J Pharm Sci; 1996 Oct 30; 85(10):1070-6. PubMed ID: 8897273
    [Abstract] [Full Text] [Related]

  • 13. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies.
    Pan F, Han L, Zhang Y, Yu Y, Liu J.
    Int J Food Sci Nutr; 2015 Oct 30; 66(6):680-5. PubMed ID: 26299896
    [Abstract] [Full Text] [Related]

  • 14. Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells.
    Vázquez M, Calatayud M, Vélez D, Devesa V.
    Toxicology; 2013 Sep 15; 311(3):147-53. PubMed ID: 23793072
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture.
    Lozoya-Agullo I, Araújo F, González-Álvarez I, Merino-Sanjuán M, González-Álvarez M, Bermejo M, Sarmento B.
    Mol Pharm; 2017 Apr 03; 14(4):1264-1270. PubMed ID: 28263609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability.
    Mahler GJ, Shuler ML, Glahn RP.
    J Nutr Biochem; 2009 Jul 03; 20(7):494-502. PubMed ID: 18715773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials.
    Ude VC, Brown DM, Stone V, Johnston HJ.
    J Nanobiotechnology; 2019 May 21; 17(1):70. PubMed ID: 31113462
    [Abstract] [Full Text] [Related]

  • 20. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
    Cai Y, Xu C, Chen P, Hu J, Hu R, Huang M, Bi H.
    J Pharmacol Toxicol Methods; 2014 May 21; 70(2):175-81. PubMed ID: 25034865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.